Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial
Roberto Ferrari, Ian Ford, Kim Fox, Jean Pascal Challeton, Anne Correges, Michał Tendera, Petr Widimský, Nicolas Danchin
Topics & Concepts
TrimetazidineMedicinePercutaneous coronary interventionPlaceboDouble blindRandomized controlled trialInternal medicinePhysical therapyCardiologyMyocardial infarctionAlternative medicinePathologyCoronary Interventions and DiagnosticsAcute Myocardial Infarction ResearchHeart rate and cardiovascular health